EXPAND: Siponimod Slows Brain Atrophy in SPMS EXPAND: Siponimod Slows Brain Atrophy in SPMS

n the phase 3 EXPAND trial, patients with secondary progressive MS receiving the investigational oral drug siponimod had less brain atrophy and fewer lesions up to 2 years compared with those receiving placebo.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news